VWR Corporation Announces Exercise of Over-Allotment Option
RADNOR, Pa., Nov. 3, 2014 /PRNewswire/ -- VWR Corporation (NASDAQ: VWR), a leading, independent provider of laboratory products, services and solutions, announced today that the underwriters of its initial public offering have exercised their over-allotment option to purchase an additional 3,826,700 shares at the initial public offering price of $21.00 per share, resulting in gross proceeds of approximately $80.4 million and net proceeds of approximately $75.9 million after deducting underwriting discounts and estimated offering expenses. After giving effect to the over-allotment closing, the total number of shares sold by VWR Corporation in its initial public offering increased to 29,358,700 shares.
BofA Merrill Lynch, Goldman, Sachs & Co. and J.P. Morgan are serving as lead joint book-running managers and as representatives of the underwriters for the offering, Barclays, Deutsche Bank Securities, Citigroup, Jefferies, and William Blair are acting as joint book-running managers for the offering, and Cowen and Company, Mizuho Securities, SMBC Nikko, Drexel Hamilton, and Loop Capital Markets are acting as co-managers.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on October 1, 2014. The offering is being made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department or by emailing [email protected]; Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by telephone at (866) 803-9204.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About VWR
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is a leading, independent provider of laboratory products, services and solutions with worldwide sales in excess of $4.1 billion in 2013. VWR enables science in laboratory and production facilities in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR offers a well-established network that reaches thousands of specialized laboratories and facilities spanning the globe. VWR has more than 8,500 associates working to streamline the way scientists, medical professionals and production engineers stock and manage their businesses. In addition, VWR supports its customers by providing other value-added service offerings, research support, laboratory services and operations services.
Logo - http://photos.prnewswire.com/prnh/20101109/NY97837LOGO
SOURCE VWR
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article